Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge

NATerminatedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Eosinophilic EsophagitisEoE
Interventions
DEVICE

Cytosponge™ Cell Collection Device

The Cytosponge™ Cell Collection Device (Cytosponge) is intended to collect surface cells from the esophagus. The device consists of a swallowable capsule, which dissolves in the body cavity, releasing a self-expandable sponge. The sponge is then retrieved from the esophagus using an attached cord. During the retrieval process, the sponge collects cells from the most superficial layer of the esophageal mucosa. Once removed from the body cavity, the sponge and cells are retained for investigation and/or testing. The Cytosponge™ Cell Collection Device (Cytosponge) received 510(k) clearance from the FDA on November 26, 2014 (K142695). The Cytosponge ™ Cell Collection device is a Class II product under 21 CFR 874.4710 esophagoscope (flexible or rigid) and accessories.

Trial Locations (2)

27516

University of North Carolina at Chapel Hill, Chapel Hill

55902

Mayo Clinic, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

University of Cambridge

OTHER

collaborator

CURED Foundation

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT02114606 - Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge | Biotech Hunter | Biotech Hunter